From development to success: The European surveillance scheme for travel associated Legionnaires' disease

European Journal of Public Health

Volumn 17, Issue 6, 2007, Pages 652-656

  Joseph, Carol A ^b   Ricketts, Katherine D ^a,b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b NONE

Author keywords

EWGLINET; Historical development; International surveillance; Legionnaires' disease

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMAN; LABORATORY DIAGNOSIS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; STATISTICAL SIGNIFICANCE; TRAVEL;

EID: 37249091245     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckm023     Document Type: Article

References (26)

1. European Working Group for Legionella Infections. European Guidelines for Control and Prevention of Travel Associated Legionnaires' Disease. 2002; PHLS London and www.ewgli.org.
2. Sharrar RG. Respiratory infection - Pennsylvania. MMWR 1976;25:244.
3. Sharrar RG. Follow-up on respiratory Illness - Philadelphia. MMWR 1977;26:9-11.
4. Legionnaires' disease: Report on a WHO Working Group. Copenhagen: WHO Regional Office for Europe, 1982 (Euro Reports and Studies, No. 72).
5. Environmental aspects of control of legionellosis: Report on a WHO meeting. Copenhagen: WHO Regional Office for Europe, 1986.
6. Report on the 1st meeting of the European Working Group on Legionella Infections, Stockholm, April 1986.
7. EWGLI - 91 Proceedings of the 6th Meeting, Elsinore, Denmark.
8. Report on the 4th meeting of the European Working Group on Legionella Infections, Oxford, England, July 1989.
9. Anon. Epidemiology, prevention and control of legionellosis. Memorandum from a WHO meeting. Bull of the World Health Organ 1990;68:155-64.
10. ENS CARE Telematics Project. 1992 European Commission DGXIII, Luxembourg.
11. OJ L268, 3.10.1998 Decision of the European Parliament and Council for the setting up of a Community Network for the epidemiological surveillance and control of communicable diseases in the Community. www.europa.eu.int/eur-lex/ pri/en/oj/dat/1998/l_268/l_26819981003en00010006.pdf. (accessed 9 November 2006).
12. Revised case definition - 13th Annual Scientific Meeting of the European Working Group for Legionella Infections, Helsinki 1998.
13. www.ewgli.org.
14. Tilton RC. Legionnaires' disease antigen detected by enzyme-linked immunosorbent assay. Ann Intern Med 1979;90:697-8.
15. Ricketts KD, Joseph CA. Legionnaires' disease in Europe 2003-2004. Euro Surveill 2005;12:256-9.
16. Joseph CA. Legionnaires' disease in Europe 2000-2002. Epidemiol Infect 2004;132:417-24.
17. Gaia V, Fry NK, Afshar B, et al. Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila. J Clin Microbiol 2005;43:2047-52.
18. Lijst met legionellahotels. NRC Handelsblad-Voorpagina. September 28 2000.
19. www.minvws.nl.
20. Decision No 2000/96/EC of the European Parliament and of the Council. OJ L28 of 3.2.2000.
21. Ricketts KD, Joseph CA. The impact of new guidelines in Europe for the control and prevention of travel-associated Legionnaires' disease. Int J Hyg Environ Health 2006;209:547-52.
22. European Council Directive 90/314/EEC of 13 June 1990 on package travel, package holidays and package tours.
23. Joseph CA, Cartwright R, Christie P, Bartlett CLR. The travel industry: an important partner in European Public Health and Travel Associated Legionnaires' Disease. 1997 Public Health Laboratary Service, London.
24. Ricketts KD, McNaught B, Joseph CA. Travel associated legionnaires' disease in Europe: 2004. Euro Surveill 2006;11(4):107-10.
25. The Freedom of Information Act (2000). http://www.opsi.gov.uk/acts/ acts2000/20000036.htm. (accessed 9 November 2006).
26. Information Commissioner's Office. Freedom of Information Act (2000) Decision notice Ref FER0126686. http://www.ico.gov.uk/upload/documents/ decisionnotices/2006/decision_notic_fer0126686.pdf. (Accessed 9 November 2006).